AzTrials
AzTrials

OsteoarthritisPhase 3NCT00208351

A Randomised Single Centre Study to Compare the Long-term Performance of 4 Designs of the DePuy Ultima LX Stem in Primary Total Hip Replacement

A Phase 3 study testing Ultima LX Collared Stem - Non-Polished/Blasted Finished, Ultima LX Collared Stem - Polished Finished and Ultima LX Collarless Stem - Non-Polished/Blasted Finished in people with Osteoarthritis and Post-traumatic Arthritis, run by DePuy International at 1 site in United Kingdom.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The purpose of this study is to compare the performance of 4 designs of the DePuy Ultima LX hip stem in the treatment of patients with hip joint disease requiring a total hip replacement. Read more about this study

Who is it for?
Ages 60 to 80 years
What is being tested?
Ultima LX Collared Stem - Non-Polished/Blasted Finished, Ultima LX Collared Stem - Polished Finished and Ultima LX Collarless Stem - Non-Polished/Blasted Finished
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
164 participants
Where
1 siteUnited Kingdom
Study dates
May 1997to Mar 2015
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Current indications for primary total hip arthroplasty utilising a cemented femoral component. These include pain, deformity and loss of function which are not responsive to medical treatment

Who cannot join

  • Revision Total Hip Arthroplasty ii) Rheumatoid arthritis iii) Age greater than 80 years at time of surgery iv) Age less than 60 years at time of surgery v) Previous hip joint sepsis vi) Obesity vii) Patient likely to remain housebound once rehabilitation is complete

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Epsom General Hospital

    Surrey, KT18 7EG

Other trials in United Kingdom

About this study

Official title: Clinical and Radiographic Evaluation to Compare a Polished and Non-polished Collared Stem and a Polished and Non Polished Collarless Stem in Primary Total Hip Replacement

The purpose of this study is to compare the performance of 4 designs of the DePuy Ultima LX hip stem in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be randomly allocated to one of the 4 designs of the DePuy Ultima LX hip stem and will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments.

Being tested
Ultima LX Collared Stem - Non-Polished/Blasted Finished, Ultima LX Collared Stem - Polished Finished, Ultima LX Collarless Stem - Non-Polished/Blasted Finished, Ultima LX Collarless Stem - Polished finished
Keywords
Hip, Cemented
Medical subject headings
Osteoarthritis, Collagen Diseases, Osteonecrosis, Hip Dislocation, Congenital, Slipped Capital Femoral Epiphyses

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultima LX Collared Stem - Non-Polished/Blasted FinishedDevice

    A collared non-polished/blasted finished cementless femoral component for use in total hip replacement.

  • Ultima LX Collared Stem - Polished FinishedDevice

    A collared polished finished cementless femoral component for use in total hip replacement.

  • Ultima LX Collarless Stem - Non-Polished/Blasted FinishedDevice

    A collarless non-polished/blasted finished cementless femoral component for use in total hip replacement.

  • Ultima LX Collarless Stem - Polished finishedDevice

    A collarless polished finished cementless femoral component for use in total hip replacement.

Study groups in NCT00208351
Study groupRoleWhat they receive
1) Ultima LX Collared Stem - Non-Polished/Blasted FinishedActive comparatorA collared non-polished blasted finished cementless femoral component for use in total hip replacement.
Receives: Device: Ultima LX Collared Stem - Non-Polished/Blasted Finished
2) Ultima LX Collared Stem - Polished FinishedActive comparatorA collared polished finished cementless femoral component for use in total hip replacement.
Receives: Device: Ultima LX Collared Stem - Polished Finished
3) Ultima LX Collarless Stem - Non-Polished/Blasted FinishedActive comparatorA collarless non-polished/blasted finished cementless femoral component for use in total hip replacement.
Receives: Device: Ultima LX Collarless Stem - Non-Polished/Blasted Finished
4) Ultima LX Collarless Stem - Polished FinishedActive comparatorA collarless polished finished cementless femoral component for use in total hip replacement.
Receives: Device: Ultima LX Collarless Stem - Polished finished

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stem movement measured radiographically at 2 years

    Stem movement was measured radiographically by comparing baseline stem position with the stem position 2 years after surgery. If migration was observed to be 5 or more mm, it was considered clinically significant migration.

    Measured: 2yrs post-surgery

Secondary outcomes (1)
  1. Comparisons of Visual Analog Pain (VAS), 36-Item Short Form Health Survey (SF-36), Satisfaction, Limb Length and stem movement measured radiographically at 5 years.

    The following outcome measures were used; VAS Pain score, SF36 Patient reported outcome, Satisfaction, Limb Length physical examination, and stem movement measured radiographically.

    Measured: 5yrs post-surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2005 (estimated)
  2. Study startMay 1997
  3. Primary completionNov 2004
  4. Study completionMar 2015

Why it stopped: The final assessments were conducted late and in a reduced format due to resource limitations at the site.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
164 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00208351
Sponsor's protocol ID
CT01/95
Status last verified
Mar 2016
First submitted
13 Sep 2005
Last updated
11 May 2016
Results posted
No
Data monitoring committee
No

Publications

  • Hutt J, Hazlerigg A, Aneel A, Epie G, Dabis H, Twyman R, Cobb A. The effect of a collar and surface finish on cemented femoral stems: a prospective randomised trial of four stem designs. Int Orthop. 2014 Jun;38(6):1131-7. doi: 10.1007/s00264-013-2256-z. Epub 2014 Jan 29.

    PubMed 24474088

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Ultima LX Collared Stem - Non-Polished/Blasted Finished, Ultima LX Collared Stem - Polished Finished and Ultima LX Collarless Stem - Non-Polished/Blasted Finished in people with Osteoarthritis and Post-traumatic Arthritis, run by DePuy International at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 11 May 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was stopped early (reason given: The final assessments were conducted late and in a reduced format due to resource limitations at the site.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stem movement measured radiographically at 2 years (time frame: 2yrs post-surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00208351, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in